Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery d
about
Device closure of secundum atrial septal defect's and the risk of cardiac erosionBeneficial effects of transcatheter closure of atrial septal defects not only in young adults.Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defectsIntermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients.Surgical repair after ineffective device closure of an inferior sinus venosus defect.Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder.Atrioventricular block after ASD closure.Successful Percutaneous Retrieval of Embolized Septal Occluder Device from Aortic Arch and Placement of a Newer Septal Occluder Device in Combined Procedure.Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.Transcatheter closure of secundum atrial septal defect.Characteristics of secundum atrial septal defects not percutaneously closed.Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study.Historical developments of atrial septal defect closure devices: what we learn from the past.Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment.Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature.Post-market surveillance to detect adverse events associated with Melody® valve implantation.Transcatheter closure of secundum atrial septal defects: has fear of device erosion altered outcomes?Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry®.Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications.Anterior Minithoracotomy: a Safe Approach for Surgical ASD Closure & ASD Device Retrieval.Surgical treatment of amplatzer embolus in a secundum atrial septal defect patient.Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement.Live/Real time three-dimensional transesophageal echocardiography in percutaneous closure of atrial septal defects.Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.Short-term outcomes of transcatheter closure of secundum atrial septal defect in children and adolescents: An experience of two centers in Upper Egypt.Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems databasClosure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.Coronary Sinus Defect Following Transcatheter Closure of ASD Using Amplatzer Septal Occluder: Potential Erosion by the Device.Impact of the Amplatzer atrial septal occluder device on left ventricular function in pediatric patients.'Near death' thromboembolic episode following device closure of atrial septal defect.Fatal Erosion Atrial Septal Defect Device.Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.Evaluation of Valsalva sinus wall deformation due to compression by the Amplatzer septal occluder and the potential for erosion development.Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder.Look before (and after) you plug: moving slowly toward safer selection and management of patients at risk of device erosion.
P2860
Q26770168-3CA1064B-2DD5-4DBF-B767-C1E8FAD5C20CQ33161080-AADE226C-AE69-4339-927A-13591145B5A9Q34203252-808E7516-A5F8-43BB-BE34-73149F720B5DQ35015042-8E720BD7-1B1C-47F0-A00E-E5BB920BE961Q35845099-B7C459E6-FFA2-4D33-8971-10A5F70796A3Q36316417-ADF62547-130F-4C32-9996-553014C00D3BQ37156410-4E000860-E321-42D1-BDAF-D27944E5CBB9Q37575415-5120AF52-19FB-4A64-8691-4AEAB43CC591Q38007112-0F7D48F7-8EF1-45EA-8301-FEBA33B3E732Q38013744-13415002-C066-4A26-AB58-1DF0B9D8CFF5Q38021360-6E455CD3-E87D-4512-8CEE-30B5F74C691CQ38081829-874B8149-A892-4FB3-BDFE-EF9F7CC44503Q38115158-A5606979-B1D1-41FD-877B-8A096948B09FQ38260239-4D2BDC9C-4A1B-4E99-B43F-9131DA613010Q38372327-2AB45C0E-B33D-4ACF-9144-AFFE459E134EQ38816969-7D91E677-C056-4BC6-B807-B64089EAD154Q38852997-14A77F6B-13BC-4C26-8901-D0B150E3E0AAQ38958010-7718A9FB-B88B-4BFA-8D65-DA4F6B0B9FC4Q39003960-E7172204-6E2A-43AB-8076-D819A5E15BA6Q39026487-7E6E92D4-E2D0-419A-B020-0B4FAB02C63CQ39143686-D9143993-8706-4C0C-9BE0-A922FD496708Q39758773-34782F57-970D-4EEE-8017-A7D2A05AEC8CQ40581714-412AF654-E32F-4FE7-ABCA-4EEFBF3EC719Q41955507-A9D49309-4BFB-4839-B64D-43F209273FC0Q42151825-572746F5-F599-4ABB-98BD-27D98CABF930Q43640732-206504B4-67DD-40F9-BEBB-3D0A5925C96CQ43755617-7F4BEC09-3194-417A-AC41-FC2B27489018Q45041490-53C67FC2-C227-410F-A646-E7ECCBA9D8DFQ47137544-F4A9BAC9-0571-4C79-AC1A-A4E6A5C98C5FQ47404445-64AE5B59-F586-437D-9120-0488F3CE365CQ47645804-684A32A1-6EC4-40D7-BC16-BCFB61460493Q47814704-0E5FFA3E-568A-493E-8D0F-5E27625FAE40Q48293440-5B5C1C90-26CC-4860-9774-F3C472FC20D9Q48727509-CAF6FB0C-41D7-410B-85CF-7BF32D52E971Q50898336-684C7993-DA8F-4F2C-B321-BE5AE9EA0580Q50986470-7ED95343-188F-4C49-9030-D9CBCF6F1740Q51061337-21B690A2-7BF2-42A0-BBD7-3B6761454FF1Q53404421-9639EB77-4E44-461A-9538-7CEF71A37BB3Q53595880-F9BA17F8-58DD-4469-BFE0-0F6599D13CFDQ53653936-50F32FAF-30FC-4E7C-BE3A-862F96EAB69D
P2860
Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery d
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@ast
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@en
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@nl
type
label
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@ast
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@en
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@nl
prefLabel
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@ast
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@en
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@nl
P2093
P2860
P1476
Analysis of the US Food and Dr ...... y congenital cardiac surgery d
@en
P2093
Aditya K Kaza
Daniel J DiBardino
Doff B McElhinney
John E Mayer
P2860
P304
P356
10.1016/J.JTCVS.2009.02.032
P407
P577
2009-06-01T00:00:00Z